CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases

To date, no curative therapy is available for the treatment of most chronic inflammatory diseases such as atopic dermatitis, rheumatoid arthritis, or autoimmune disorders. Current treatments require a lifetime supply for patients to alleviate clinical symptoms and are unable to stop the course of di...

Descripción completa

Detalles Bibliográficos
Autores principales: Akinrinmade, Olusiji A., Chetty, Shivan, Daramola, Adebukola K., Islam, Mukit-ul, Thepen, Theo, Barth, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618314/
https://www.ncbi.nlm.nih.gov/pubmed/28895912
http://dx.doi.org/10.3390/biomedicines5030056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618314/
https://www.ncbi.nlm.nih.gov/pubmed/28895912
http://dx.doi.org/10.3390/biomedicines5030056

Ejemplares similares